The potential rise in new-onset diabetes could be a crucial factor to consider when treating patients with topical corticosteroids, particularly during more aggressive skin treatments. Further research is necessary to validate these observations across diverse populations.

Citation: van der Linden MW, Penning-van Beest FJ, Nijsten T, Herings RM. Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands. Drug Saf. 2009;32(6):527-37. doi: 10.2165/00002018-200932060-00008. PMID: 19459719.